CD14 and esophageal squamous cell carcinoma: The mean percentage of CD11b+CD14+HLA-DR− cells relative to the total number of CD11b+ myeloid cells in the PBMCs of esophageal SCC patients was 42.2±9.7% compared to 5.18±1.3% in healthy donors.